Serum uromodulin may indicate acute kidney injury in COVID-19 patients

Serum uromodulin (sUmod) represents a promising biomarker for acute kidney injury (AKI) in COVID-19 patients, as reported in a published collaborative study between EUROIMMUN, St Georg Hospital ...

Another piece of the puzzle in rheumatological diagnostics

Systemic autoimmune rheumatic diseases encompass a wide range of different inflammatory joint, tissue and vascular diseases, such as rheumatoid arthritis, systemic lupus erythematosus and systemic ...

Two companies, one goal

Panadea and EUROIMMUN are two companies with one common important goal: The development, production and distribution of test systems for the detection of the pathogens causing such emerging diseases, ...

Well prepared for the flu season: diagnostics in the interest of public health

Well prepared for the flu season: diagnostics in the interest of public health

At regular intervals, sometimes daily, the latest influenza figures are published. National health authorities around ...

The new potential gold standard for myasthenia gravis autoantibody diagnostics

Myasthenia gravis (MG) is an autoimmune-mediated myasthenic disorder with the main symptom of exertion-related muscle weakness. The disease results from functional loss of the nicotinic acetylcholine ...

Novel autoantibody associated with Hodgkin’s lymphoma

Autoantibodies targeting the protein RGS8 (regulator of G-protein signaling 8) are associated with a particular subtype of Hodgkin’s lymphoma, as described in a recently published study performed in a ...

The Evolution of Microscopy: A Glimpse Through the Lens

The world of science has long relied on the ability to explore the unseen. From the first rudimentary lenses to today’s advanced imaging systems, microscopy has transformed our understanding of life ...

Breathe easily in the cold season: How to reliably identify adenoviruses as the cause of respiratory diseases

Currently, many patients are presenting themselves at the doctor’s with symptoms of the common cold, such as cough, runny nose, headache and fever. These symptoms are typical of this time of year and ...

Approval of Alzheimer's drug in Europe - APOE genotyping gets important

On 14th November 2024, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency announced their positive opinion on the marketing authorisation of lecanemab ...

Chemiluminescence immunoassays support diagnosis of Alzheimer’s disease

EUROIMMUN chemiluminescence immunoassays (ChLIA) for Alzheimer’s disease (AD) biomarkers provide reliable analytical and clinical performance, as demonstrated in two newly published studies performed ...

Back to top